Second, the effect of tumor-produced OPG strongly depends on the levels of RANKL in the bone tissue: at low RANKL levels, OPG is predominantly inhibitory, while at high RANKL levels, tumor-produced OPG becomes more effective in inducing osteolysis (Figure 5-C, compare  and ). The gene discussed is TNFRSF11B; the disease is neoplasm.